2024-10-09 - Analysis Report
## HCA Healthcare Inc. (HCA) Stock Analysis Report

**1.  Performance Comparison:**

HCA Healthcare Inc. (HCA) is a leading provider of healthcare services in the United States. Its stock has outperformed the S&P 500 (VOO) significantly.

* **HCA's Cumulative Return:** 321.43%
* **S&P 500 (VOO) Cumulative Return:** 133.14%
* **Return Difference:** 188.29%
* **Relative Divergence:** 93.43% 

This indicates that HCA has outperformed the market significantly over time,  currently sitting at the 93.43% percentile of its historical performance relative to the S&P 500.

**2.  Recent Price Movement:**

* **Closing Price:** $394.07
* **5-Day Moving Average:** $400.45
* **20-Day Moving Average:** $398.88
* **60-Day Moving Average:** $374.67

The stock price is currently trading below its 5-day and 20-day moving averages, indicating a potential short-term downward trend. However, the 60-day moving average suggests a longer-term upward trend.

**3. Technical Indicators:**

* **RSI:** 36.53 -  This indicates that the stock is currently in oversold territory.
* **PPO:** -0.57 - This suggests a short-term weakness in price momentum.
* **Delta_Previous_Relative_Divergence:** -3.61 - This negative value indicates a recent decline in relative strength.
* **Expected Return:** 0.88% - This indicates a potential 5-year expected return above the S&P 500 (VOO).

These indicators suggest a potential for a short-term price correction but with a long-term positive outlook.

**4. Recent Earnings and Outlook:**

| Date       | EPS      | Revenue        |
| ---------- | -------- | --------------- |
| 2024-07-29 | 5.6      | $17.49 Billion |
| 2024-05-02 | 6.01     | $17.34 Billion |
| 2023-10-26 | 3.98     | $16.21 Billion |
| 2023-08-02 | 4.35     | $15.86 Billion |
| 2024-07-29 | 4.35     | $15.86 Billion |

HCA has consistently shown strong revenue growth and EPS performance in recent quarters. The most recent earnings report for Q2 2024 exceeded analyst expectations, demonstrating the company's continued strong performance.

**5. News and Recent Issues:**

HCA is experiencing strong performance with its recent earnings report exceeding expectations.  Analysts are generally optimistic about HCA's growth prospects, citing its strong market position, operational efficiency, and continued investment in technology and infrastructure. However, the company is facing headwinds from rising labor costs and inflation, which are pressuring margins. Despite these challenges, HCA remains well-positioned for continued growth in the long term.

**6.  Summary:**

HCA has a strong track record of outperforming the market, supported by consistent revenue growth and earnings performance. The company's recent earnings report exceeded expectations, further solidifying its position as a leading healthcare provider. Despite near-term challenges, HCA remains well-positioned for continued growth and has a positive outlook based on its financial performance and industry trends. 

**7. Recommendations:**

Considering HCA's strong fundamentals and recent performance, it could be a valuable addition to a diversified investment portfolio, especially for long-term investors. However, it's important to monitor the company's progress closely and be aware of the potential risks, such as rising labor costs and inflation. 
